
Company valuation, historical trends, and peer comparisons.
According to KALA BIO, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 3.10M. This represents a change of 1.17% compared to the average of 3.06M of the last 4 quarters.
The mean historical Enterprise Value of KALA BIO, Inc. over the last ten years is 7.01B. The current 3.10M Enterprise Value has changed -99.96% with respect to the historical average. Over the past ten years (40 quarters), KALA's Enterprise Value was at its highest in in the June 2020 quarter at 29.25B. The Enterprise Value was at its lowest in in the December 2016 quarter at -35818000.00.
Average
7.01B
Median
5.15B
Minimum
-3026573.00
Maximum
19.57B
Discovering the peaks and valleys of KALA BIO, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 202.42%
Maximum Annual Enterprise Value = 19.57B
Minimum Annual Increase = -140.82%
Minimum Annual Enterprise Value = -3026573.00
| Year | Enterprise Value | Change |
|---|---|---|
| 2025 | -3026573.00 | -140.82% |
| 2024 | 7.42M | 202.42% |
| 2023 | 2.45M | -91.95% |
| 2022 | 30.47M | -99.23% |
| 2021 | 3.97B | -77.67% |
| 2020 | 17.78B | 180.99% |
| 2019 | 6.33B | -2.20% |
| 2018 | 6.47B | -66.94% |
| 2017 | 19.57B | 22.77% |
| 2016 | 15.94B | -0.25% |
The current Enterprise Value of KALA BIO, Inc. (KALA) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
2.28M
5-year avg
801.55M
10-year avg
7.01B
KALA BIO, Inc.’s Enterprise Value is greater than AIM ImmunoTech Inc. (595.66K), greater than Oragenics, Inc. (-2189797.00), greater than Pasithea Therapeutics Corp. (-32862707.00), less than VYNE Therapeutics Inc. (155.58M), greater than Can-Fite BioPharma Ltd. (759.26K), less than Ensysce Biosciences, Inc. (7.40M), less than Impact BioMedical Inc. (35.02M), less than XTL Biopharmaceuticals Ltd. (4.58M), greater than Soligenix, Inc. (-1657744.00), greater than Abpro Corporation (-1588660.00),
| Company | Enterprise Value | Market cap |
|---|---|---|
| 595.66K | $6.57M | |
| -2189797.00 | $1.67M | |
| -32862707.00 | $12.80M | |
| 155.58M | $19.07M | |
| 759.26K | $2.11M | |
| 7.40M | $7.88M | |
| 35.02M | $35.03M | |
| 4.58M | $1.65M | |
| -1657744.00 | $7.85M | |
| -1588660.00 | $1.06M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like KALA BIO, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like KALA BIO, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is KALA BIO, Inc.'s Enterprise Value?
What is the highest Enterprise Value for KALA BIO, Inc. (KALA)?
What is the 3-year average Enterprise Value for KALA BIO, Inc. (KALA)?
What is the 5-year average Enterprise Value for KALA BIO, Inc. (KALA)?
How does the current Enterprise Value for KALA BIO, Inc. (KALA) compare to its historical average?